Metabolic brain changes in post-acute COVID-19: systematic review and meta-analysis of [18F]-FDG-PET findings
Authors:
- Izabella Fernanda Bastos SiqueiraISIzabella Fernanda Bastos Siqueira
- Lais Almeida FigueiredoLFLais Almeida Figueiredo
- Camila Emanuele Moreira FernandesCFCamila Emanuele Moreira Fernandes
- Leandro Pinheiro CintraLCLeandro Pinheiro Cintra
- Glauber Fernandes de OliveiraGOGlauber Fernandes de Oliveira
- Maria Angélica RiosMRMaria Angélica Rios
- Ricardo MacielRMRicardo Maciel
- Rodrigo FerretjansRFRodrigo Ferretjans
- Nathalia Sernizon GuimarãesNGNathalia Sernizon Guimarães
- Luiz Alexandre Viana MagnoLMLuiz Alexandre Viana Magno
- 7 August 2025
- journal article
- review article
- Published by Springer Nature in Brain Structure and Function
- Vol. 230 (7) , 1-15
Abstract
Individuals with long COVID exhibit neurological and psychiatric symptoms that often persist well beyond the initial SARS-CoV-2 infection. Studies using [18F]-FDG positron emission tomography (FDG-PET) have revealed diverse abnormalities in brain glucose metabolism during the post-acute phase of COVID-19. We conducted a systematic review and meta-analysis to assess the spatial distribution and heterogeneity of brain metabolic changes in patients in the post-acute phase of COVID-19 relative to controls. We searched the MEDLINE, EMBASE, and CENTRAL databases in June 2025 for studies reporting FDG-PET data in patients with post-acute COVID-19 who have persistent neurological symptoms. Of the 14 eligible studies (584 scans), 13 reported glucose hypometabolism across frontoparietal regions, with the frontal cortex being the most consistently affected. This finding was confirmed by meta-analysis, which revealed a large and significant effect in the frontal cortex (Hedges’ g = 1.34; 95% CI: 0.79–1.88; p < 0.001), despite high heterogeneity (I2 = 93.6%). The systematic review indicates that brain metabolism generally improves over time, with widely varying recovery timelines, and consistently correlates hypometabolism with neurological symptom burden. These findings underscore the clinical relevance of frontoparietal hypometabolism in post-acute COVID-19 and its association with neurocognitive deficits, highlighting the need for longitudinal, quantitative PET studies to elucidate temporal dynamics and inform therapeutic development.Keywords
This publication has 61 references indexed in Scilit:
- Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptomsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [18F]FDG-PET studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Brain 18F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristicsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysisAlzheimer's & Dementia, 2022
- 18F-FDG brain PET hypometabolism in patients with long COVIDEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Structural and metabolic brain abnormalities in COVID-19 patients with sudden loss of smellEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Cochrane Handbook for Systematic Reviews of Interventions2019
- A comparison of methods to detect publication bias in meta‐analysisStatistics in Medicine, 2001